Previous 10 | Next 10 |
Fisher Healthcare, a part of Thermo Fisher Scientific, will become the non-exclusive national laboratory distribution partner alongside OpGen, Inc.’s direct sales in the U.S. for the Unyvero A50 platform Initial focus on FDA cleared Unyvero LRT (BAL) cartridges for hospitalized pne...
Based on large multi-center study with over 1,800 patient samples Primary endpoint for Unyvero UTI for urinary tract infection was successfully met and shows overall weighted average sensitivity of 96.8% and overall weighted average specificity of 97.4% Submission follows FDA ...
2023-04-05 09:03:39 ET Precision medicine company, OpGen ( NASDAQ: OPGN ) signed an amendment to its research and development collaboration agreement with FIND, to expand the collaboration which was originally started in fall of 2022. The work already completed under ...
Parties add several deliverables to initial R&D collaboration contract Overall potential revenue increased to up to euro 830 thousand ROCKVILLE, Md., April 05, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a pre...
PREPLEX project is part of broader InfectoGnostics Research Campus in Jena, Germany Total project volume of PREPLEX collaborative research is approximately $ 0.9 Mio ROCKVILLE, Md., April 03, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “...
2023-03-30 15:34:33 ET OpGen ( NASDAQ: OPGN ) is trading 12.5% lower after Q4 GAAP EPS missed estimates as operating costs rose during the quarter. The company's revenues declined 49.7% Y/Y to $0.72M due to the termination of the FISH product line and the one-off non-exclu...
ROCKVILLE, Md., March 30, 2023 (GLOBE NEWSWIRE) -- In a release published March 29, 2023 under the same headline by OpGen, Inc. (Nasdaq: OPGN), the financial tables were incorrect. The corrected release follows: Total revenue for 2022 was approximately $2.6 million ...
2023-03-30 10:02:34 ET Gainers: SCYNEXIS ( SCYX ) +61% . Palisade Bio ( PALI ) +33% . Biophytis ( BPTS ) +10% . RenovoRx ( RNXT ) +9% . VYNE Therapeutics ( VYNE ) +9% . Losers: AngioDynamics ( ANGO ) -28% . ...
2023-03-29 18:22:04 ET OpGen, Inc. (OPGN) Q4 2022 Earnings Conference Call March 29, 2023, 04:30 PM ET Company Participants Oliver Schacht - President and CEO Albert Weber - CFO Conference Call Participants Nidhi Singh - Edison Group Yi Chen - H.C. Wa...
2023-03-29 16:25:41 ET OpGen press release ( NASDAQ: OPGN ): Q4 GAAP EPS of -$3.87 misses by $1.87 . Revenue of $0.72M (-49.7% Y/Y). Cash and cash equivalents as of December 31, 2022 were approximately $7.4 million, a decrease compared to the balance at December 31...
News, Short Squeeze, Breakout and More Instantly...
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...
Gelesis Holdings, Inc. (GLSHQ) is expected to report for Q1 2024 EVmo Inc (YAYO) is expected to report for Q1 2024 Chiba Bank Ltd. ADR (CHBAY) is expected to report for Q4 2024 Spark Networks SE (LOVLQ) is expected to report for Q1 2024 ToughBuilt Industries Inc. (TBLT) is expecte...